Palo Alto Investors LP - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 50 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 2.0%.

Quarter-by-quarter ownership
Palo Alto Investors LP ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$562,000
-47.1%
669,449
-30.1%
0.03%
-58.2%
Q3 2014$1,063,000
-51.6%
958,026
-20.2%
0.08%
-51.8%
Q2 2014$2,197,000
-48.6%
1,200,800
-58.0%
0.16%
-7.3%
Q1 2014$4,274,000
+63.4%
2,858,348
+100.0%
0.18%
-27.5%
Q4 2013$2,615,000
-63.8%
1,429,174
-59.3%
0.24%
-67.8%
Q3 2013$7,229,000
-17.6%
3,509,2050.0%0.76%
-26.8%
Q2 2013$8,773,0003,509,2051.04%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,866,483$4,285,0002.24%
Sarissa Capital Management LP 2,570,759$3,843,0001.32%
Greylock XI GP Limited Partnership 584,004$876,0000.56%
Deer VI & Co. LLC 675,242$1,013,0000.44%
DAFNA Capital Management LLC 261,507$391,0000.34%
Palo Alto Investors LP 2,858,348$4,274,0000.18%
Baupost Group 3,829,350$5,725,0000.14%
SABBY MANAGEMENT, LLC 573,416$857,0000.05%
Granahan Investment Management 676,451$1,011,0000.03%
TFS CAPITAL LLC 176,633$264,0000.02%
View complete list of AVEO PHARMACEUTICALS INC shareholders